National Cancer Institute; Amended Notice of Meeting, 85222 [2024-24876]
Download as PDF
ddrumheller on DSK120RN23PROD with NOTICES1
85222
Federal Register / Vol. 89, No. 207 / Friday, October 25, 2024 / Notices
Contact Person: Joann Wu Shortt, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–3333, shorttjw@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Radiation Therapy, Radiation
Biology and Nanoparticle Based
Therapeutics.
Date: November 14–15, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jennifer Ann Sanders,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 496–3553, jennifer.sanders@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Infectious Diseases and
Immunology B Review Panel.
Date: November 14–15, 2024.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Diana Maria Ortiz-Garcia,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–5614, diana.ortiz-garcia@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Molecular Bacterial Pathogenesis
and Host Defense.
Date: November 14, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Joshua D. Powell, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–5370, josh.powell@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Bioengineering, Biomaterials, and
Instrumentation.
Date: November 14–15, 2024.
Time: 10:00 a.m. to 8:40 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Joseph Thomas Peterson,
Ph.D., Scientific Review Office, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
VerDate Sep<11>2014
17:40 Oct 24, 2024
Jkt 265001
MSC 7814, Bethesda, MD 20892, 301–408–
9694, petersonjt@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Respiratory, Cardiac, and
Circulatory Sciences.
Date: November 14, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Eugene Carstea, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4130,
MSC 7818, Bethesda, MD 20892, (301) 408–
9756, carsteae@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Endocrinology, Metabolism, and
Reproduction.
Date: November 14–15, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Baskaran Thyagarajan,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 800B,
Bethesda, MD 20892, (301) 867–5309,
thyagarajanb2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–RM–
24–007, SCGE Phase II, Assays and
Technologies for Genome Editing.
Date: November 14, 2024.
Time: 2:30 p.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Karobi Moitra, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 480–6893,
karobi.moitra@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 22, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–24880 Filed 10–24–24; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Board of Scientific
Counselors, National Cancer Institute,
November 4, 2024, 10 a.m. to November
4, 2024, 4:40 p.m., National Institute of
Health, Building 31, C Wing, 6th Floor,
Conference Room C, 9000 Rockville
Pike, Bethesda, MD 20892 which was
published in the Federal Register on
October 1, 2024, FR Doc 2024–22437, 89
FR 79937.
This meeting notice is being amended
to change the meeting format from
hybrid to virtual. The meeting is
partially Closed to the public.
Dated: October 21, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–24876 Filed 10–24–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Epidemiology and Population
Health.
Date: November 20, 2024.
Time: 10 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Cynthia C. McOliver,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
E:\FR\FM\25OCN1.SGM
25OCN1
Agencies
[Federal Register Volume 89, Number 207 (Friday, October 25, 2024)]
[Notices]
[Page 85222]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24876]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Board of
Scientific Counselors, National Cancer Institute, November 4, 2024, 10
a.m. to November 4, 2024, 4:40 p.m., National Institute of Health,
Building 31, C Wing, 6th Floor, Conference Room C, 9000 Rockville Pike,
Bethesda, MD 20892 which was published in the Federal Register on
October 1, 2024, FR Doc 2024-22437, 89 FR 79937.
This meeting notice is being amended to change the meeting format
from hybrid to virtual. The meeting is partially Closed to the public.
Dated: October 21, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-24876 Filed 10-24-24; 8:45 am]
BILLING CODE 4140-01-P